MAY 14, 2020 7:52 PM PDT

Therapeutic for Gastrointestinal Tumors

WRITTEN BY: Nouran Amin

The FDA has approved ripretinib (Qinlock) which is the first drug for fourth-line treatment of advanced gastrointestinal stromal tumors (GIST). The therapeutic is approved for use in adults who have previously received treatment with 3 or more kinase inhibitor therapies, including imatinib, sunitinib, and regorafenib. When patients do not respond to these treatments, they may be prescribed Qinlock.

GIST results when abnormal cells form in the tissues of the gastrointestinal tract. These tumors most likely form in the stomach, small intestine, and large intestine.

Learn more about GIST, which affects roughly 6,000 adults annually in the United States:

“GIST is a complex disease and the majority of patients who initially respond to traditional tyrosine kinase inhibitors eventually develop tumor progression due to secondary mutations,” said Margaret von Mehren, MD, chief of sarcoma oncology and associate director for clinical research at Fox Chase Cancer Center.

Treatment for GIST using Qinlock was granted approval after findings of the INVICTUS study through the Fast Track designation and Priority Review by the FDA, in addition to the Breakthrough Therapy designation.

Some noted side-effects of Qinlcok use includes alopecia, fatigue, vomiting, and a variety of additional gastrointestinal complications. Treatment may also adversely affect a developing fetus during pregnancy and may be a risk for skin cancer, hypertension, and cardiac dysfunction.

“In the INVICTUS study, Qinlock has demonstrated compelling clinical benefit in progression-free and overall survival. Qinlock is well tolerated and is a crucial new therapy for these patients with a high unmet need.”

Source: AJMC

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 24, 2020
Cancer
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
AUG 24, 2020
Inhibiting Cancer Stem Cells to Stop Cancer Recurrence
Once upon a time, stem cells were the talk of the town. They really are amazing, with some capable of turning into any o ...
AUG 24, 2020
Drug Discovery & Development
New Drug Reduces Swelling in Asthma and COPD
AUG 24, 2020
New Drug Reduces Swelling in Asthma and COPD
Researchers from the University of Glasgow, Scotland, and the University of Technology Sydney in Australia have identifi ...
SEP 08, 2020
Space & Astronomy
New Drug May Allow Astronauts to Spend Years in Space
SEP 08, 2020
New Drug May Allow Astronauts to Spend Years in Space
Without gravity from Earth, muscles and bones tend to weaken quickly. To combat this, astronauts usually need to spend t ...
SEP 07, 2020
Drug Discovery & Development
Improving Antirejection Medications in Heart Transplant
SEP 07, 2020
Improving Antirejection Medications in Heart Transplant
Placing patients on anti-rejection drugs is reality for all heart transplant patients. As such, recent research at Johns ...
OCT 03, 2020
Cannabis Sciences
Cannabis Compound Prevents Colon Cancer in Mice
OCT 03, 2020
Cannabis Compound Prevents Colon Cancer in Mice
Second only to skin cancer, colon cancer is the most common cancer diagnosed in both men and women in the US. Now, resea ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
Loading Comments...